Fourier Rehab and Brooks Rehabilitation Sign Strategic MOU to Advance Research in Robotic Neurorehabilitation

Fourier Rehab, a global leader in intelligent rehabilitation robotics, has signed a strategic Memorandum of Understanding (MOU) with Brooks Rehabilitation, a leader in physical rehabilitation for more than 50 years. This partnership establishes a collaborative framework to explore advanced clinical research using Fourier Rehab’s flagship robotic technologies—ArmMotus™ EMU and ExoMotus™ M4—at Brooks Rehabilitation’s cutting-edge Center for Innovation in Florida.

Fourier Rehab will deploy its flagship upper- and lower-limb robotic rehabilitation systems at Brooks Rehabilitation as part of the collaboration. These technologies will be integrated into Brooks’ research and clinical environment, where multidisciplinary teams will explore their clinical applications and potential to enhance therapeutic practices. Known for their intelligent assistance features, adaptive therapy modes, and real-time feedback, the systems will serve as a platform for ongoing innovation in rehabilitation care.

This MOU highlights both organizations’ shared vision to push the boundaries of evidence-based care by leveraging robotics, AI, and data analytics. The partnership aims to generate new clinical insights, validate best practices, and accelerate the adoption of high-tech rehabilitation tools in mainstream healthcare.

“Brooks Rehabilitation has an extraordinary legacy in clinical excellence and translational research. By combining our advanced robotics with Brooks’ deep clinical expertise and research infrastructure, we are taking a bold step toward shaping the future of rehabilitation science and redefining recovery pathways for patients worldwide,” said Owen Teoh, managing director of Fourier Rehab International Division.

“As one of the world leaders in rehabilitation technology and robotics, we are incredibly enthusiastic to collaborate with Fourier Rehab and for the potential of this partnership,” said Mark Bowden, PhD, PT, vice president of Clinical Integration and Research for Brooks Rehabilitation. “This collaboration is in perfect alignment with the Brooks Rehabilitation Center for Innovation’s mission of identifying the most efficient and effective ways to deliver rehabilitation to maximize a patient’s functional potential.”

This collaboration represents a significant milestone in Fourier Rehab’s commitment to research-driven innovation and its mission to empower clinicians and improve lives through intelligent therapy systems. With ArmMotus™ EMU and ExoMotus™ M4 now in place at Brooks, the partnership will pave the way for robust joint studies and the co-creation of scalable therapy protocols informed by clinical data.

From Left to Right: Mallory Smith, research operations manager, Brooks Rehabilitation; Owen Teoh, managing director, Fourier Rehab International Division; Mark Bowden, vice president, Clinical Integration and Research, Brooks Rehabilitation; Sarah Lim, support services director, Fourier Rehab International Division.